Cogle CR - Search Results

1

Therapeutics for Graft-versus-Host Disease: From Conventional Therapies to Novel Virotherapeutic Strategies.

Villa NY, Rahman MM, McFadden G, Cogle CR. Villa NY, et al. Among authors: cogle cr. Viruses. 2016 Mar 22;8(3):85. doi: 10.3390/v8030085. Viruses. 2016. PMID: 27011200 Free PMC article. Review.

2

Myxoma virus targets primary human leukemic stem and progenitor cells while sparing normal hematopoietic stem and progenitor cells.

Kim M, Madlambayan GJ, Rahman MM, Smallwood SE, Meacham AM, Hosaka K, Scott EW, Cogle CR, McFadden G. Kim M, et al. Among authors: cogle cr. Leukemia. 2009 Dec;23(12):2313-7. doi: 10.1038/leu.2009.219. Epub 2009 Oct 29. Leukemia. 2009. PMID: 19865109 Free PMC article. No abstract available.

3

Oncolytic viral purging of leukemic hematopoietic stem and progenitor cells with Myxoma virus.

Rahman MM, Madlambayan GJ, Cogle CR, McFadden G. Rahman MM, et al. Among authors: cogle cr. Cytokine Growth Factor Rev. 2010 Apr-Jun;21(2-3):169-75. doi: 10.1016/j.cytogfr.2010.02.010. Epub 2010 Mar 7. Cytokine Growth Factor Rev. 2010. PMID: 20211576 Free PMC article. Review.

4

Oncolytic virotherapy for hematological malignancies.

Bais S, Bartee E, Rahman MM, McFadden G, Cogle CR. Bais S, et al. Among authors: cogle cr. Adv Virol. 2012;2012:186512. doi: 10.1155/2012/186512. Epub 2011 Oct 29. Adv Virol. 2012. PMID: 22312362 Free PMC article.

5

Acute myeloid leukemia targeting by myxoma virus in vivo depends on cell binding but not permissiveness to infection in vitro.

Madlambayan GJ, Bartee E, Kim M, Rahman MM, Meacham A, Scott EW, McFadden G, Cogle CR. Madlambayan GJ, et al. Among authors: cogle cr. Leuk Res. 2012 May;36(5):619-24. doi: 10.1016/j.leukres.2012.01.020. Epub 2012 Feb 17. Leuk Res. 2012. PMID: 22341701 Free PMC article.

6

Selective purging of human multiple myeloma cells from autologous stem cell transplantation grafts using oncolytic myxoma virus.

Bartee E, Chan WM, Moreb JS, Cogle CR, McFadden G. Bartee E, et al. Among authors: cogle cr. Biol Blood Marrow Transplant. 2012 Oct;18(10):1540-51. doi: 10.1016/j.bbmt.2012.04.004. Epub 2012 Apr 16. Biol Blood Marrow Transplant. 2012. PMID: 22516053 Free PMC article.

7

Virotherapy using myxoma virus prevents lethal graft-versus-host disease following xeno-transplantation with primary human hematopoietic stem cells.

Bartee E, Meacham A, Wise E, Cogle CR, McFadden G. Bartee E, et al. Among authors: cogle cr. PLoS One. 2012;7(8):e43298. doi: 10.1371/journal.pone.0043298. Epub 2012 Aug 14. PLoS One. 2012. PMID: 22905251 Free PMC article.

8

Prevention of EBV lymphoma development by oncolytic myxoma virus in a murine xenograft model of post-transplant lymphoproliferative disease.

Kim M, Rahman MM, Cogle CR, McFadden G. Kim M, et al. Among authors: cogle cr. Biochem Biophys Res Commun. 2015 Jul 10;462(4):283-7. doi: 10.1016/j.bbrc.2015.03.146. Epub 2015 Apr 2. Biochem Biophys Res Commun. 2015. PMID: 25843801

9

Myxoma virus suppresses proliferation of activated T lymphocytes yet permits oncolytic virus transfer to cancer cells.

Villa NY, Wasserfall CH, Meacham AM, Wise E, Chan W, Wingard JR, McFadden G, Cogle CR. Villa NY, et al. Among authors: cogle cr. Blood. 2015 Jun 11;125(24):3778-88. doi: 10.1182/blood-2014-07-587329. Epub 2015 Apr 22. Blood. 2015. PMID: 25904246 Free PMC article.

10

Ex vivo virotherapy with myxoma virus does not impair hematopoietic stem and progenitor cells.

Villa NY, Bais S, Chan WM, Meacham AM, Wise E, Rahman MM, Moreb JS, Rosenau EH, Wingard JR, McFadden G, Cogle CR. Villa NY, et al. Among authors: cogle cr. Cytotherapy. 2016 Mar;18(3):465-80. doi: 10.1016/j.jcyt.2015.12.007. Cytotherapy. 2016. PMID: 26857235 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

144 results

Search Page